Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Beta-cyclodextrin (β-CD) is a cyclic oligosaccharide composed of seven glucose units, known for its ability to form inclusion complexes with hydrophobic molecules, enhancing their solubility and stability. It is widely used in pharmaceutical, food, and cosmetic industries due to its unique cavity structure that can encapsulate guest molecules. Studies have demonstrated its utility in improving the aqueous solubility of poorly soluble compounds like curcumin, forming supramolecular complexes, and serving as a scaffold for multifunctional host compounds, such as Schiff base derivatives for metal coordination. Additionally, β-CD derivatives have been explored in regioselective chemical modifications and as components in molecular devices, highlighting its versatility in both scientific and industrial applications.

7585-39-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 7585-39-9 Structure
  • Basic information

    1. Product Name: Betadex
    2. Synonyms: BETA BYCLODEXTRIN;BW 7;CavaMax W 7;CAVAMAX W7 PharMa;Celdex B 100;Celdex B 100H;Celdex B 100z;Celdex N
    3. CAS NO:7585-39-9
    4. Molecular Formula: C42H70O35
    5. Molecular Weight: 1134.98
    6. EINECS: 231-493-2
    7. Product Categories: Inhibitors;Industrial/Fine Chemicals;Biochemistry;Cyclodextrins;Functional Materials;Macrocycles for Host-Guest Chemistry;Oligosaccharides;Sugars;Dextrins、Sugar & Carbohydrates;Cosmetic Ingredients & Chemicals
    8. Mol File: 7585-39-9.mol
  • Chemical Properties

    1. Melting Point: >260 °C (dec.)(lit.)
    2. Boiling Point: 844.96°C (rough estimate)
    3. Flash Point: 908.5oC
    4. Appearance: white/powder
    5. Density: 1.2296 (rough estimate)
    6. Vapor Pressure: 0mmHg at 25°C
    7. Refractive Index: 1.7500 (estimate)
    8. Storage Temp.: +15C to +30C
    9. Solubility: 1 M NaOH: 50 mg/mL
    10. PKA: 11.73±0.70(Predicted)
    11. Water Solubility: Soluble in water and ammonium hydroxide.
    12. Stability: Stable. Incompatible with strong oxidizing agents.
    13. Merck: 14,2718
    14. BRN: 78623
    15. CAS DataBase Reference: Betadex(CAS DataBase Reference)
    16. NIST Chemistry Reference: Betadex(7585-39-9)
    17. EPA Substance Registry System: Betadex(7585-39-9)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38-20
    3. Safety Statements: 26-36-24/25
    4. WGK Germany: 2
    5. RTECS: GU2293000
    6. TSCA: Yes
    7. HazardClass: N/A
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 7585-39-9(Hazardous Substances Data)

7585-39-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 7585-39-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,5,8 and 5 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 7585-39:
(6*7)+(5*5)+(4*8)+(3*5)+(2*3)+(1*9)=129
129 % 10 = 9
So 7585-39-9 is a valid CAS Registry Number.
InChI:InChI=1/C42H70O35.H2O/c43-1-8-29-15(50)22(57)36(64-8)72-30-9(2-44)66-38(24(59)17(30)52)74-32-11(4-46)68-40(26(61)19(32)54)76-34-13(6-48)70-42(28(63)21(34)56)77-35-14(7-49)69-41(27(62)20(35)55)75-33-12(5-47)67-39(25(60)18(33)53)73-31-10(3-45)65-37(71-29)23(58)16(31)51;/h8-63H,1-7H2;1H2

7585-39-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (C0777)  β-Cyclodextrin  >99.0%(HPLC)

  • 7585-39-9

  • 25g

  • 565.00CNY

  • Detail
  • TCI America

  • (C0777)  β-Cyclodextrin  >99.0%(HPLC)

  • 7585-39-9

  • 100g

  • 2,290.00CNY

  • Detail
  • USP

  • (1154569)  BetaCyclodextrin  United States Pharmacopeia (USP) Reference Standard

  • 7585-39-9

  • 1707908-30MG

  • 25,262.64CNY

  • Detail
  • USP

  • (1154569)  BetaCyclodextrin  United States Pharmacopeia (USP) Reference Standard

  • 7585-39-9

  • 1154569-250MG

  • 4,662.45CNY

  • Detail
  • Sigma-Aldrich

  • (PHR1439)  Beta-Cyclodextrin  pharmaceutical secondary standard; traceable to USP

  • 7585-39-9

  • PHR1439-1G

  • 791.15CNY

  • Detail
  • Sigma

  • (C4767)  β-Cyclodextrin  ≥97%

  • 7585-39-9

  • C4767-25G

  • 635.31CNY

  • Detail
  • Sigma

  • (C4767)  β-Cyclodextrin  ≥97%

  • 7585-39-9

  • C4767-100G

  • 1,962.09CNY

  • Detail
  • Sigma

  • (C4767)  β-Cyclodextrin  ≥97%

  • 7585-39-9

  • C4767-500G

  • 6,148.35CNY

  • Detail
  • Sigma-Aldrich

  • (B0950000)  Betadex  European Pharmacopoeia (EP) Reference Standard

  • 7585-39-9

  • B0950000

  • 1,880.19CNY

  • Detail

7585-39-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name β-cyclodextrin

1.2 Other means of identification

Product number -
Other names FEMA 4028

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only. Uncategorized
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7585-39-9 SDS

7585-39-9Synthetic route

6A,6B,6D,6E-tetradeoxy-2A,2B,2C,2D,2E,2F,2G,3A,3B,3C,3D,3E,3F,3G,6C,6F,6G-heptadeca-O-benzyl-β-cyclodextrin

6A,6B,6D,6E-tetradeoxy-2A,2B,2C,2D,2E,2F,2G,3A,3B,3C,3D,3E,3F,3G,6C,6F,6G-heptadeca-O-benzyl-β-cyclodextrin

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen In tetrahydrofuran; water regioselective reaction;100%
mono-6-deoxy-6-(p-tolylsulphonyl)-β-cyclodextrin
67217-55-4

mono-6-deoxy-6-(p-tolylsulphonyl)-β-cyclodextrin

A

Mono-3A,6A-anhydrocyclomaltoheptaose
104867-20-1

Mono-3A,6A-anhydrocyclomaltoheptaose

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With sodium hydroxide In water at 40℃; for 11h;A 87.9%
B 8.2%
mono-6-deoxy-6-formyl-β-cyclodextrin
159496-21-6

mono-6-deoxy-6-formyl-β-cyclodextrin

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With sodium tetrahydroborate In water for 24h; Ambient temperature;72%
With sodium tetrahydroborate In methanol; water for 1h;
mono-6-deoxy-6-(p-tolylsulphonyl)-β-cyclodextrin
67217-55-4

mono-6-deoxy-6-(p-tolylsulphonyl)-β-cyclodextrin

A

6(I)-amino-6(I)-deoxycyclomaltoheptaose
29390-67-8

6(I)-amino-6(I)-deoxycyclomaltoheptaose

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With ammonia In water at 60℃; for 5h; Product distribution / selectivity;A 70%
B 30%
C42H70O35*C37H47N3(2+)*2Br(1-)
141484-64-2

C42H70O35*C37H47N3(2+)*2Br(1-)

A

C37H47N3(2+)*2Br(1-)
141484-62-0

C37H47N3(2+)*2Br(1-)

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
In water-d2 at 30℃; Equilibrium constant; Thermodynamic data; other temperatures; free energy of activation at 70 deg C;
C42H70O35*C6H13N3OS

C42H70O35*C6H13N3OS

A

3-t-butyl-1-methyl-1-nitrosothiourea
95598-14-4

3-t-butyl-1-methyl-1-nitrosothiourea

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With acetate buffer at 37℃; Rate constant; dissociation constant and catalyzed rate constant of the inclusion complex is determined;
C42H70O35*C12H14N2
114987-36-9

C42H70O35*C12H14N2

A

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

B

1,1'-dimethyl-1,1'-dihydro-4,4'-bipyridyl
25128-26-1

1,1'-dimethyl-1,1'-dihydro-4,4'-bipyridyl

Conditions
ConditionsYield
In water at 25℃; Equilibrium constant;
prostacyclin*β-cyclodextrin
77164-53-5

prostacyclin*β-cyclodextrin

A

7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-((E)-(S)-3-hydroxy-oct-1-enyl)-cyclopentyl]-6-oxo-heptanoic acid
58962-34-8

7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-((E)-(S)-3-hydroxy-oct-1-enyl)-cyclopentyl]-6-oxo-heptanoic acid

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With phosphate buffer (pH=ca. 7); water at 10 - 30℃; Thermodynamic data; Kinetics; activation parameters: ΔS(excit.), ΔG(excit.), E investigated;
C42H70O35*C21H34O5
69377-76-0

C42H70O35*C21H34O5

A

6-keto-PGF1α methyl ester
63557-55-1

6-keto-PGF1α methyl ester

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With phosphate buffer (pH=ca. 7); water at 10 - 30℃; Thermodynamic data; Kinetics; activation parameters: ΔS(excit.), ΔG(excit.), E investigated;
C42H70O35*C15H17BrNO(1+)*Br(1-)
80800-15-3

C42H70O35*C15H17BrNO(1+)*Br(1-)

A

trimethylammonium bromide
80214-62-6

trimethylammonium bromide

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With Co(NH3)6 at 25℃; Rate constant; Equilibrium constant; host-guest complexation of cyclodextrins with detergents, photoluminescence study;
C42H70O35*C19H25BrNO(1+)*Br(1-)
80800-16-4

C42H70O35*C19H25BrNO(1+)*Br(1-)

A

trimethylammonium bromide
79671-16-2

trimethylammonium bromide

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With Co(NH3)6 at 25℃; Rate constant; Equilibrium constant; host-guest complexation of cyclodextrins with detergents, photoluminescence study;
C42H70O35*C24H35BrNO(1+)*Br(1-)
80822-21-5

C42H70O35*C24H35BrNO(1+)*Br(1-)

A

trimethylammonium bromide
79671-17-3

trimethylammonium bromide

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With Co(NH3)6 at 25℃; Rate constant; Equilibrium constant; host-guest complexation of cyclodextrins with detergents, photoluminescence study;
C42H70O35*C6H15NO3

C42H70O35*C6H15NO3

A

triethanolamine
102-71-6

triethanolamine

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
In water at 25℃; Equilibrium constant; further temperatures;
C42H70O35*C20H15O2(1-)*Na(1+)

C42H70O35*C20H15O2(1-)*Na(1+)

A

sodium 4-pyren-1-ylbutyrate
63442-80-8

sodium 4-pyren-1-ylbutyrate

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
In water at 25℃; Equilibrium constant; Thermodynamic data; quenching by triethanolamine, ΔH(excit), ΔS(excit), further temperatures;
2C42H70O35*C20H15O2(1-)*Na(1+)

2C42H70O35*C20H15O2(1-)*Na(1+)

A

C42H70O35*C20H15O2(1-)*Na(1+)

C42H70O35*C20H15O2(1-)*Na(1+)

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
In water at 25℃; Equilibrium constant; Thermodynamic data; quenching by triethanolamine, ΔH(excit), ΔS(excit), further temperatures;
β‐cyclodextrin
7585-39-9

β‐cyclodextrin

heptakis(6-bromo-6-deoxy)-β-cyclodextrin
53784-83-1

heptakis(6-bromo-6-deoxy)-β-cyclodextrin

Conditions
ConditionsYield
With bromine; triphenylphosphine In N,N-dimethyl-formamide at 0 - 80℃; for 15h;100%
With tetraethylammonium bromide; 4-pyrrolidin-1-ylpyridine; ethanaminium,N-(difluoro-λ4-sulfanylidene)-N-ethyl-,tetrafluoroborate In N,N-dimethyl-formamide at 20℃; regioselective reaction;97%
With bromine; triphenylphosphine In N,N-dimethyl-formamide at 75 - 80℃;95%
allyl bromide
106-95-6

allyl bromide

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

heptakis(2,3,6-tri-O-allyl)-β-cyclodextrin
141126-40-1

heptakis(2,3,6-tri-O-allyl)-β-cyclodextrin

Conditions
ConditionsYield
Stage #1: β‐cyclodextrin With sodium hydride In N,N-dimethyl-formamide at 60℃; for 2.5h;
Stage #2: allyl bromide In N,N-dimethyl-formamide at 60℃; for 16h; Further stages.;
100%
Stage #1: β‐cyclodextrin With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0 - 5℃; for 1h;
Stage #2: allyl bromide In N,N-dimethyl-formamide; mineral oil at 0 - 20℃;
98%
Stage #1: β‐cyclodextrin With sodium hydride In N,N-dimethyl-formamide; mineral oil at 20℃; for 0.5h; Inert atmosphere;
Stage #2: allyl bromide In N,N-dimethyl-formamide; mineral oil at 20℃; Inert atmosphere;
88%
With sodium hydride In N,N-dimethyl-formamide at 20 - 23℃; for 13h;49%
β‐cyclodextrin
7585-39-9

β‐cyclodextrin

β-CD-fenchene

β-CD-fenchene

Conditions
ConditionsYield
Stage #1: fenchene; β‐cyclodextrin In 1,4-dioxane; water at 20℃; for 0.25h;
Stage #2: In water at 20 - 75℃;
100%
C23H28B10N4OPt(2+)*2NO3(1-)

C23H28B10N4OPt(2+)*2NO3(1-)

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
C23H28B10N4OPt(2+)*2NO3(1-)

C23H28B10N4OPt(2+)*2NO3(1-)

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
C23H28B10N4OPt(2+)*2NO3(1-)

C23H28B10N4OPt(2+)*2NO3(1-)

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
C23H28B10N4OPt(2+)*2NO3(1-)

C23H28B10N4OPt(2+)*2NO3(1-)

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
C23H28B10N4OPt(2+)*2NO3(1-)

C23H28B10N4OPt(2+)*2NO3(1-)

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
C23H28B10N4OPt(2+)*2NO3(1-)

C23H28B10N4OPt(2+)*2NO3(1-)

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
C23H28B10N4OPt(2+)*2NO3(1-)

C23H28B10N4OPt(2+)*2NO3(1-)

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
[Pt((S)-(1,7-closo-carboran-1-yl)pyrid-3-ylmethanol)2(1,10-phenanthroline)](NO3)2

[Pt((S)-(1,7-closo-carboran-1-yl)pyrid-3-ylmethanol)2(1,10-phenanthroline)](NO3)2

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

[Pt((S)-(1,7-closo-carboran-1-yl)pyrid-3-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

[Pt((S)-(1,7-closo-carboran-1-yl)pyrid-3-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
[Pt((S)-(1,12-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)](NO3)2

[Pt((S)-(1,12-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)](NO3)2

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

[Pt((S)-(1,12-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

[Pt((S)-(1,12-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
[Pt((R)-(1,7-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)](NO3)2

[Pt((R)-(1,7-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)](NO3)2

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

[Pt((R)-(1,7-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

[Pt((R)-(1,7-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
[Pt((S)-(1,7-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)](NO3)2

[Pt((S)-(1,7-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)](NO3)2

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

[Pt((S)-(1,7-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

[Pt((S)-(1,7-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
[Pt((R)-(1,7-closo-carboran-1-yl)pyrid-3-ylmethanol)2(1,10-phenanthroline)](NO3)2

[Pt((R)-(1,7-closo-carboran-1-yl)pyrid-3-ylmethanol)2(1,10-phenanthroline)](NO3)2

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

[Pt((R)-(1,7-closo-carboran-1-yl)pyrid-3-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

[Pt((R)-(1,7-closo-carboran-1-yl)pyrid-3-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
benzyl chloride
100-44-7

benzyl chloride

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

2,3,6-Tri-O-benzyl-β-cyclomaltoheptaose
129318-82-7, 130322-65-5, 130322-67-7

2,3,6-Tri-O-benzyl-β-cyclomaltoheptaose

Conditions
ConditionsYield
With sodium hydride In dimethyl sulfoxide at 20℃; for 22h; Inert atmosphere; Schlenk technique;99%
With sodium hydride In dimethyl sulfoxide; mineral oil at 20℃; Inert atmosphere;96%
With sodium hydride In dimethyl sulfoxide95%
3,4,5,6-tetrahydro-2H-pyran-2-one
542-28-9

3,4,5,6-tetrahydro-2H-pyran-2-one

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

polymer; monomer(s): β-cyclodextrin; δ-valerolactone

polymer; monomer(s): β-cyclodextrin; δ-valerolactone

Conditions
ConditionsYield
at 100℃; for 48h;98%
acetic anhydride
108-24-7

acetic anhydride

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

per-O-acetylated β-cyclodextrin

per-O-acetylated β-cyclodextrin

Conditions
ConditionsYield
With copper(II) perchlorate hexahydrate In neat (no solvent) at 20℃; for 0.25h; Inert atmosphere;98%
1,1,1,3,3,3-hexamethyl-disilazane
999-97-3

1,1,1,3,3,3-hexamethyl-disilazane

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

heptakis(2,6-di-O-trimethylsilyl)cyclomaltoheptaose

heptakis(2,6-di-O-trimethylsilyl)cyclomaltoheptaose

Conditions
ConditionsYield
With trimethylsilyl trifluoromethanesulfonate In dichloromethane at 20℃; for 0.25h; Inert atmosphere; regioselective reaction;97%
With iodine at 20℃; Neat (no solvent); Air atmosphere;96%
C20H20N2*2ClH

C20H20N2*2ClH

ClH*C17H16N4
1427351-20-9

ClH*C17H16N4

cucurbituril
80262-44-8

cucurbituril

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C54H52N10*C42H70O35*2C36H36N24O12*4ClH

C54H52N10*C42H70O35*2C36H36N24O12*4ClH

Conditions
ConditionsYield
In water at 60℃; for 0.5h; Huisgen Cycloaddition;97%
2CBP·2Cl

2CBP·2Cl

N-(3,5-dimethoxybenzyl)propargylammonium chloride

N-(3,5-dimethoxybenzyl)propargylammonium chloride

cucurbituril
80262-44-8

cucurbituril

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C42H52N10O4*4ClH*C42H70O35*2C36H36N24O12

C42H52N10O4*4ClH*C42H70O35*2C36H36N24O12

Conditions
ConditionsYield
In water at 20℃; for 1h;97%
1-(2-ethoxyethyl)-4-(pentyn-1-yl)-4-benzoyloxypiperidine oxalate

1-(2-ethoxyethyl)-4-(pentyn-1-yl)-4-benzoyloxypiperidine oxalate

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C42H70O35*C21H29NO3*C2H2O4

C42H70O35*C21H29NO3*C2H2O4

Conditions
ConditionsYield
In ethanol; water97%
Conditions
ConditionsYield
In ethanol; water at 25℃;96.3%
4-(cyclopropylethynyl)-1-(2-ethoxyethyl)-4-(propionyloxy)piperidine

4-(cyclopropylethynyl)-1-(2-ethoxyethyl)-4-(propionyloxy)piperidine

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

β-cyclodextrin

β-cyclodextrin

Conditions
ConditionsYield
In ethanol; water at 50 - 55℃;96.3%
tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

heptakis(6-O-tert-butyldimethylsilyl)-β-cyclodextrin
123155-03-3

heptakis(6-O-tert-butyldimethylsilyl)-β-cyclodextrin

Conditions
ConditionsYield
With pyridine at 20℃; for 18.6667h; Inert atmosphere;96%
With pyridine 1) ice bath, 6.5 h; 2) 18 h, rt;95%
With pyridine90%
acetic anhydride
108-24-7

acetic anhydride

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

peracetylated β-cyclodextrin
23739-88-0

peracetylated β-cyclodextrin

Conditions
ConditionsYield
With iodine at 20℃; for 24h; neat (no solvent);96%
With 1,4-diaza-bicyclo[2.2.2]octane at 55℃; for 4.5h; Neat (no solvent);96%
With lithium perchlorate for 50h; Heating;93%

7585-39-9Relevant articles and documents

Photoreactive nanomatrix structure formed by graft-copolymerization of 1,9-nonandiol dimethacrylate onto natural rubber

Yamamoto, Yoshimasa,Suksawad, Patjaree,Pukkate, Nanthaporn,Horimai, Tatsuya,Wakisaka, Osamu,Kawahara, Sciichi

, p. 2418 - 2424 (2010)

Formation of photoreactive nanomatrix structure was investigated by graft-copolymerization of an inclusion complex of 1,9-nonandiol dimethacrylate (NDMA) with β-cyclodextrin (β-CD) onto natural rubber particle using potassium persulfate (KPS), iert-butyl hydroperoxide/tetraethylenepentamine (TBHPO/TEPA), cumene hydroperoxide/tetraethylenepentamine (CHPO/TEPA), and benzoyl peroxide (BPO) as an initiator. The graft copolymer was characterized by 1H NMR and FTlR after coagulation. The conversion of NDMA and the amount of residual methacryloyl group were found to be 58.5 w/w % and 1.81 w/w %, respectively, under the suitable condi tion of the graft-copolymerization. The morphology of the film specimen, prepared from the graft copolymer, was observed by transmission electron microscopy (TEM) after staining the film with OsO4. Natural rubber particle of about 1.0 μm in diameter was dispersed in poly(NDMA) matrix of about 10 nm in thickness.

Effect of the reaction temperature on the transglycosylation reactions catalyzed by the cyclodextrin glucanotransferase from Bacillus macerans for the synthesis of large-ring cyclodextrins

Qi, Qingsheng,She, Xiaoyan,Endo, Tomohiro,Zimmermann, Wolfgang

, p. 799 - 806 (2004)

The synthesis of cyclodextrins with from 6 to more than 50 glucose units by cyclodextrin glucanotransferase (CGTase, EC 2.4.1.19) from Bacillus macerans was investigated. Analysis of the synthesized cyclic α-1,4-glucan products showed that a higher yield of large-ring cyclodextrins were obtained with a reaction temperature of 60°C compared to 40°C. The yield of large-ring cyclodextrins obtained at 60°C represented about 50% of the total glucans employed in the reaction. Analysis of the cyclodextrin-forming cyclization reaction and of the coupling reaction of the CGTase resulting in the degradation of mainly the larger cyclic α-1,4-glucans indicated higher rates of the cyclization reaction at 60°C compared to 40°C while the opposite was found for the coupling reaction.

Water-soluble inclusion complexes of trans-polydatin by cyclodextrin complexation: Preparation, characterization and bioactivity evaluation

Zhang, Jian-Qiang,Jiang, Kun-Ming,Xie, Xiao-Guang,Jin, Yi,Lin, Jun

, p. 592 - 598 (2016)

The inclusion complexes of trans-polydatin (PD) with β-CD and γ-CD were prepared. The inclusion complexation behavior, characterization and interactions of PD with CDs were investigated in both the solution and the solid state by means of UV-vis, ESI-MS, NMR, FT-IR, XRD, SEM, TG and DSC. All of the characterization information demonstrated the formation of PD/CDs inclusion complex, and the PD/CDs inclusion complexes exhibited different spectroscopic features and properties from PD. The 1:1 stoichiometry of the complexes was visually proven with the ESI-MS experiment and Job's method. Meanwhile, it was the phenyl group (a and b rings) of the PD molecule that were included in the CDs cavity from the wide side. Moreover, the water solubility of PD/CDs was significantly improved from 0.161 mg/mL to 7.21 mg/mL (PD/β-CD) and 12.02 mg/mL (PD/γ-CD). Consequently, the bioavailability of PD/CDs inclusion complexes were effectively improved over free PD in vitro. The present study provides useful information for the potential application of complexation with PD, a naturally occurring hydrophobic polyphenolic compounds herbal medicine.

Photochromism of dithienylethenes included in cyclodextrins

Takeshita, Michinori,Kato, Nobuo,Kawauchi, Susumu,Imase, Tatsuya,Watanabe, Junji,Irie, Masahiro

, p. 9306 - 9313 (1998)

The effect of inclusion of diarylethenes in cyclodextrin cavities on cyclization quantum yields and on circular dichroism (CD) spectral changes by photoirradiation was studied. The addition of β-and γ-cyclodextrins to an aqueous solution of the open-ring form of 2,2'-dimethyl-3,3'-(perfluoro- cyclopentene-1,2-diyl)bis(benzo[b]thiophene-6-sulfonate) (1a) increased the ratio of the antiparallel conformation. The enrichment of antiparallel conformation caused an increase in the photocyclization quantum yield of 1a. The CD spectral intensity of the mixtures of 1a or 2,2'4,4'-tetramethyl- 3,3'-(perfluorocyclopentene-1,2-dyl)bis(thiophen-5-yl-(phenyl-4-sulfonate)) (2a) and cyclodextrins in aqueous solution increased with the increasing concentration of cyclodextrins. The induced CD spectrum of 1 in β- cyclodextrin reversibly changed from negative to positive by UV irradiation. The spectral change was attributed to the change in the direction of transition moment of 1 in the cavity.

A general method for the synthesis of cyclodextrinyl aldehydes and carboxylic acids

Yoon,Hong,Martin,Czarnik

, p. 2792 - 2795 (1995)

The selective synthesis of the primary-side monoaldehyde of β-cyclodextrin, 6-deoxy-6-formyl-β-cyclodextrin, was accomplished by oxidation of the corresponding tosylate utilizing the Nace reaction (DMSO/collidine). This monoaldehyde was then used as the starting material in several reactions including reduction, addition of NaHSO3, addition of the α-nucleophiles hydroxylamine and hydrazine, and reductive amination. Of particular interest is the conversion of the monoaldehyde to the primary side carboxylic acid, 6-deoxy-6-carboxy-β-cyclodextrin, via bromine oxidation. This general method sequence can be applied to any tosyl derivative of cyclodextrin as demonstrated in the synthesis of β-cyclodextrin-A,D-dialdehyde and β-cyclodextrin-A,D-diacid.

Characterization of cyclodextrin glycosyltransferase immobilized on silica microspheres via aminopropyltrimethoxysilane as a spacer arm

Matte, Carla Roberta,Nunes, Michael Ramos,Benvenutti, Edilson Valmir,Schoeffer, Jessie Da Natividade,Ayub, Marco Antonio Zachia,Hertz, Plinho Francisco

, p. 51 - 56 (2012)

In this work, the enzymatic properties of immobilized cyclodextrin glycosyltransferase (CGTase) of Thermoanaerobacter sp. were investigated and compared with the soluble form of the enzyme. CGTase was immobilized on mesoporous silica microspheres synthesized using polyethylene glycol 400 as swelling agent, silanized with 3-aminopropyltrimethoxysilane (APTMS), and activated with glutaraldehyde prior to immobilization. This innovative approach for support preparation produced high yields of immobilization (83%) and activity recoveries (73%), which are the highest so far reported for CGTase. The soluble enzyme (CGTase) and its immobilized form (ImCGTase) showed similar values for the optimal pH activity, while optimal reaction temperatures were found to be 100 °C and 80 °C, respectively. The immobilized enzyme showed similar values for Km and thermal stabilities with the soluble form, while its Vmax was lower. The immobilized enzyme was tested in repeated batches in order to simulate recovery and reuse, keeping about 60% of the initial catalytic activity after 15 cycles, showing its good chemical and mechanical resistance.

Host - Guest interactions of 4-carboxyphenoxy phthalocyanines and β-cyclodextrins in aqueous media

Leng, Xuebing,Choi, Chi-Fung,Luo, Hai-Bin,Cheng, Yuen-Kit,Ng, Dennis K. P.

, p. 2497 - 2500 (2007)

β-Cyclodextrin and its permethylated derivatives form 2:1 inclusion complexes with tetrakis- and octakis(4-carboxyphenoxy)phthalocyanines 1-4, reducing their aggregation tendency and promoting their sensitization of singlet oxygen formation in aqueous media.

Preservation of Bacillus firmus strain 37 and optimization of cyclodextrin biosynthesis by cells immobilized on loofa sponge

Pazzetto, Rubia,De Souza Ferreira, Sabrina Barbosa,Santos, Elder James Silva,Moriwaki, Cristiane,Guedes, Teresinha Aparecida,Matioli, Graciette

, p. 9476 - 9488 (2012)

The preservation of Bacillus firmus strain 37 cells by lyophilization was evaluated and response surface methodology (RSM) was used to optimize the β-cyclodextrin (β-CD) production by cells immobilized on loofa sponge. Interactions were studied with the variables temperature, pH and dextrin concentration using a central composite design (CCD). Immobilization time influence on β-CD production was also investigated. B. firmus strain 37 cells remained viable after one year of storage, showing that the lyophilization is a suitable method for preservation of the microorganism. From the three-dimensional diagrams and contour plots, the best conditions for β-CD production were determined: temperature 60 °C, pH 8, and 18% dextrin. Considering that the amount of dextrin was high, a new assay was carried out, in which dextrin concentrations of 10, 15, and 18% were tested and the temperature of 60 °C and pH 8 were maintained. The results achieved showed very small differences and therefore, for economic reasons, the use of 10% dextrin is suggested. Increasing the immobilization time of cells immobilized on synthetic sponge the β-CD production decreased and did not change for cells immobilized on loofa sponge. The results of this research are important for microorganism preservation and essential in the optimization of the biosynthesis of CD.

An NMR study of cyclodextrin complexes of the steroidal neuromuscular blocker drug Rocuronium Bromide

Cameron, Kenneth S.,Fletcher, Dan,Fielding, Lee

, p. 251 - 260 (2002)

The interaction of Rocuronium Bromide, anda model steroid Org 7402, with three cyclodextrins (β-cyclodextrin, γ-cyclodextrin and Org 25969) was studied by solution state NMR experiments. Stoichiometries and binding constants were determined from 1/s

Chiral recognition for the complexation dynamics of β-cyclodextrin with the enantiomers of 2-naphthyl-1-ethanol

Tang, Hao,Sutherland, Andria S. M.,Osusky, Lana M.,Li, Yan,Holzwarth, Josef F.,Bohne, Cornelia

, p. 358 - 369 (2014)

The focus of this study is to understand the origin of the chiral recognition for a host-guest system containing complexes with different stoichiometries. Each enantiomer of 2-naphthyl-1-ethanol forms two different 1:1 complexes with β-cyclodextrin, leading to the formation of three different 2:2 complexes. One of these 2:2 complexes leads to excimer emission of the guest. Fluorescence studies were employed to determine the binding isotherms for the 1:1 and 2:2 complexes. No chiral discrimination was directly observed for the formation of the 1:1 complexes, while higher equilibrium constants (29% from binding isotherms and 40% from kinetic studies) were observed for the formation of the 2:2 complexes with (R)-2-naphthyl-1-ethanol when compared to the formation of the 2:2 complexes formed from (S)-2-naphthyl-1-ethanol. The relaxation kinetics was studied using stopped-flow experiments. The formation of the 2:2 complexes was followed by detecting the excimer emission from one of the 2:2 complexes. The relaxation kinetics was faster for (S)-2-naphthyl-1- ethanol, where a higher dissociation rate constant, by 47%, was observed, suggesting that the chiral discrimination occurs because the interaction between two cyclodextrins is more favorable for the complexes containing (R)-2-naphthyl-1-ethanol when compared to (S)-2-naphthyl-1-ethanol. The same overall equilibrium constants were observed for the 1:1 complexes with both enantiomers showing that at a given cyclodextrin concentration the sum of the two types of 1:1 complexes is the same for both enantiomers. However, analysis of the binding isotherms indicates that the ratio between the two different 1:1 complexes for each enantiomer was different for (R)- and (S)-2-naphthyl-1- ethanol. The Royal Society of Chemistry and Owner Societies.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 7585-39-9